Table 1.
Survivors (n = 59) | Non-survivors (n = 11) | p-value | |
Male sex, n (%) | 31 (52.5%) | 5 (45.4%) | 0.66 |
Age*) (years) | 64 (55 to 76) | 68 (59 to 82) | 0.22 |
Diabetes mellitus, n (%) | 18 (30.5%) | 6 (54.5%) | 0.12 |
Site of infection | 33 (55.9%) | 5 (45.5%) | |
Lung, n (%) | |||
Genitourinary tract, n (%) | 16 (27.1%) | 4 (36.3%) | 0.78 |
Other, n (%) | 10 (17.0%) | 2 (18.2%) | |
PaO2/FiO2¶) ratio, median±SD | 209±120 | 131±101 | 0.04 |
Creatinine (mg/dl), median±SD | 1.98±1.65 | 2.80±2.04 | 0.14 |
Bilirubin# (mg/dl), median±SD | 1.67±3.03 | 3.73±7.25 | 0.16 |
Lactemia§ (mg/dl), median±SD | 3.14±1.88 | 5.00±4.26 | 0.08 |
Platelet count (103/mm3), median±SD | 194±115 | 189±112 | 0.88 |
C-reactive protein¥ (mg/dl), median±SD | 19.1±10.44 | 13.4±8.84 | 0.13 |
Septic shock, n (%) | 22 (37.3%) | 8 (72.7%) | 0.029 |
APACHE II score*) | 19 (13 to 27) | 38 (24 to 41) | <0.001 |
SOFA score*) | 7 (4 to 11) | 11 (8 to 14) | 0.02 |
AGP (mg/dl), median±SD | 179.8±61.4 | 132.18±50.2 | 0.01 |
Variable expressed as median (25th to 75th percentiles);
n = 68 patients (57 survivors×11 non-survivors); #n = 58 patients (50 survivors×8 non-survivors); §n = 69 patients (58 survivors×11 non-survivors); ¥n = 62 patients (52 survivors×10 non-survivors).
APACHE, Acute Physiology and Chronic Health Evaluation; Pa02/FI02, arterial partial pressure of oxygen/fraction of inspired oxygen ratio; SD: standard deviation; SOFA, Sequential Organ Failure Assessment score.